Advisory Board
 The Accidental Entrepeneurs:
New York Times Article
Dr. Caplan is a prominent medical ethicist and scientist who specializes in identifying ways to improve the research process. Dr. Caplan holds various positions at the University of Pennsylvania School of Medicine, including the Emmanuel and Robert Hart Professor of Bioethics, Chair of the Department of Medical Ethics and the Director of the Center for Bioethics. He is the author or editor of 25 books and over 500 papers in journals of medicine, science, philosophy, bioethics and health policy as well as a regular columnist for MSNBC.com.
Dr. Caplan has served on numerous international and national committees including the Chair of the Advisory Committee to the United Nations on Human Cloning and the Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability. Caplan received a Ph.D. in the history and philosophy of science from Columbia University.
George S. Chu, Ph.D., executive vice president for The Kinnamon Group, a firm that provides consulting/outsourcing services to public and private sector clients, has more than 25 years of experience in healthcare mergers/acquisitions, healthcare corporate finance and healthcare operations.
Dr. Chu began his career in healthcare by directing the inpatient clinical operations of the world-renowned Philadelphia Child Guidance Clinic, a pioneer in the psychiatric treatment of children and their families. He has been an advisor to healthcare corporations in strategic planning and corporate finance as well as provided consulting and interim management services to various corporations such as Alvarez & Marsal and Linc Financial Services.
Dr. Chu received a Ph.D. in clinical psychology from Adelphi University and an M.B.A. from The Wharton School of Finance at the University of Pennsylvania.
A special advisor to Tunnell Consulting in the areas of regulatory strategy, R&D, and clinical manufacturing, Alex is a respected U.S. and foreign regulatory expert who brings exceptional industry knowledge to our firm. He is a former Senior Vice President of Worldwide Regulatory Affairs at Schering-Plough Research Institute, a former Senior Vice President of Global Compliance at Schering-Plough Corporation, and was one of the original members of the steering committee of the International Conference on Harmonization, where he introduced the concept of the common technical document (CTD). His extensive pharmaceutical industry career also includes numerous professional and academic positions, including serving as chairman of the Regulatory Affairs Coordinating Committee of the Pharmaceutical Research and Manufacturers Association, lecturing on drug law at Temple University, and serving on the planning committee at the University of Texas for their program on the International Conference for Drug Development. Alex is a member of numerous professional associations and uses his more than 30 years of expertise to help foster advancement in the life sciences environment at a time of critical and widespread industry change.
Dr. Giaquinto received a Ph.D. in Pharmaceutics from University of Connecticut and a B.S. in Pharmacy from St. John’s University College of Pharmacy.
Dr. Gonen is board certified in Internal Medicine and Endocrinology/Metabolism, with 11 years experience in academic medicine (last academic position: Associate Professor of Medicine and acting head of the Endocrine division at Thomas Jefferson Medical College in Philadelphia), and 15 years in the Pharmaceutical Industry (including senior R&D positions at Wyeth for 10 years and Teva Pharmaceuticals for 2 years). He has directed all stages of clinical development (mostly in areas of Diabetes, Obesity, Bone disease, Neurology and Cardiovascular/Lipid disorders), and reviewed hundreds of products and companies (for licensing, M&A and investment activities). Dr. Gonen is also an editor for http://www.infocapsules.com, a resource for encapsulated news and commentary for drugs in clinical development.
Mr. John R. Iona is the President and Chief Executive Officer of PhysioMetrics, Inc. Mr. Iona joined PhysioMetrics in April of 2003 following four years with Storeroom Solutions, Inc., where he served as its President and Chief Operations Officer. Prior to that post, he served as Senior Vice President & General Manager of Day & Zimmermann International, Inc., where he was responsible for a subsidiary focused on providing engineering and technical services to the nuclear power industry. Mr. Iona has also held key leadership positions with The General Physics Corporation, Public Service Electric & Gas Company and The Singer Company. He is a native New Yorker, raised in northern New Jersey and University of Delaware alum. He and his family reside in suburban Philadelphia.
Ed Marlowe is President and CEO and co-founder of NFG Stuff, LLC, a company created to develop, manufacture and market hair care products to teen boys and young men. He recently retired as the Chairman of the Paper Mill Playhouse in Millburn, NJ, one of the largest regional theaters in the country.
In June 2000, Ed Marlowe retired from Bristol-Myers Squibb Beauty Care Division as Senior Vice President of Research and Development. There, he was responsible for all scientific and technical operations for the Clairol, Clairol Professional, Clairol International, Matrix, and Redmond divisions and companies. Dr. Marlowe joined the management team in 1992 when the company was a $300M division. The products developed under his supervision propelled the division to grow to over $3B by June 2000. Among Dr. Marlowe's accomplishments was the development of the Herbal Essence product line, Amplify. He also led the establishment of new safety standards for hair coloring products that have been adopted throughout the world.
Prior to joining Clairol, Dr. Marlowe was Corporate VP and President Consumer Products Research and Development Division for Warner Lambert where he was responsible for the worldwide research and development activities from 1981-1991. Dr. Marlowe had a string of consumer product successes including the anti-plaque, anti-gingivitis claims for Listerine including the seal of approval of the American Dental Association, creating a "good tasting" Cool Mint Listerine and the Rx to OTC switch of Benadryl.
From 1972 to 1981, Dr. Marlowe was VP R&D for the Consumer Health Products Division of Schering-Plough. Prior to this Dr. Marlowe held various positions at Whitehall Labs, Ortho Pharmaceuticals, and Merck. He was responsible for the development of the Sun Protection Factor (SPF) system and testing methods that were adopted by the FDA as well as the formulation of the first SPF-15 Sunblock product (Super Shade by Coppertone).
Ed received his B.S. and M.S. in Pharmaceutical Chemistry from Columbia University and his Ph.D. in Pharmaceutical Chemistry and Pharmacology from the University of Maryland.
|
